A. Mékinian

15.3k total citations
231 papers, 4.4k citations indexed

About

A. Mékinian is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, A. Mékinian has authored 231 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Rheumatology, 58 papers in Pulmonary and Respiratory Medicine and 52 papers in Immunology. Recurrent topics in A. Mékinian's work include Systemic Lupus Erythematosus Research (42 papers), Vasculitis and related conditions (39 papers) and Otitis Media and Relapsing Polychondritis (30 papers). A. Mékinian is often cited by papers focused on Systemic Lupus Erythematosus Research (42 papers), Vasculitis and related conditions (39 papers) and Otitis Media and Relapsing Polychondritis (30 papers). A. Mékinian collaborates with scholars based in France, Spain and United States. A. Mékinian's co-authors include O. Fain, Michaël Soussan, É. Hachulla, Jaume Alijotas‐Reig, David Launay, Lionel Carbillon, P. Nicaise‐Roland, Olivier Fain, Gabriel Pop and Patrick Nicolas and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

A. Mékinian

205 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Mékinian France 38 1.4k 1.2k 1.1k 697 626 231 4.4k
Tim Bongartz United States 25 2.1k 1.5× 996 0.9× 882 0.8× 576 0.8× 598 1.0× 45 4.5k
O. Fain France 37 1.4k 1.0× 801 0.7× 888 0.8× 634 0.9× 815 1.3× 203 4.2k
T. Papo France 44 2.1k 1.4× 1.5k 1.3× 1.6k 1.4× 624 0.9× 1.2k 1.9× 245 6.4k
Alexis Mathian France 41 2.3k 1.6× 758 0.7× 3.2k 2.8× 522 0.7× 418 0.7× 135 5.9k
Christian Dejaco Austria 40 2.8k 2.0× 2.6k 2.2× 1.1k 1.0× 335 0.5× 553 0.9× 209 5.4k
Carl Turesson Sweden 45 4.6k 3.2× 1.5k 1.3× 1.2k 1.1× 702 1.0× 907 1.4× 170 6.6k
Alexandre Karras France 40 880 0.6× 1.2k 1.0× 1.3k 1.2× 492 0.7× 866 1.4× 164 5.1k
Véronique Le Guern France 29 1.9k 1.4× 996 0.9× 622 0.6× 481 0.7× 216 0.3× 111 3.4k
Achille Aouba France 30 1.2k 0.9× 1.4k 1.2× 433 0.4× 277 0.4× 299 0.5× 157 2.8k
Antonio Fernández‐Nebro Spain 32 2.6k 1.8× 368 0.3× 1.2k 1.1× 535 0.8× 562 0.9× 153 3.7k

Countries citing papers authored by A. Mékinian

Since Specialization
Citations

This map shows the geographic impact of A. Mékinian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mékinian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mékinian more than expected).

Fields of papers citing papers by A. Mékinian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mékinian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mékinian. The network helps show where A. Mékinian may publish in the future.

Co-authorship network of co-authors of A. Mékinian

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mékinian. A scholar is included among the top collaborators of A. Mékinian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mékinian. A. Mékinian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guédon, Alexis F., et al.. (2025). Cardiovascular events in patients with myositis: results from a French retrospective cohort. RMD Open. 11(1). e005276–e005276. 1 indexed citations
2.
Zhao, Lin‐Pierre, Vincent Jachiet, Olivier Kosmider, et al.. (2025). Very long-term remission with azacitidine in VEXAS syndrome. Haematologica. 110(6). 1432–1435. 1 indexed citations
3.
Weeks, Lachelle D., Danielle Hammond, Sinisa Savic, et al.. (2025). Establishing a consensus definition of VEXAS flare for clinical research. Lara D. Veeken. 65(2).
4.
Bourguiba, R., Valentin Lacombe, David B. Beck, et al.. (2025). Characterizing VEXAS syndrome in women: Findings from an international multicenter study. Journal of Internal Medicine. 298(5). 516–524.
6.
Guédon, Alexis F., et al.. (2024). Aortitis Increases Risk of Relapse and Vascular Events in Takayasu Arteritis. Mayo Clinic Proceedings. 99(3). 504–507. 1 indexed citations
7.
Abisror, Noémie, Jonathan Cohen, Aurore Coulomb, et al.. (2024). Intravenous Immunoglobulins for Recurrent Chronic Histiocytic Intervillositis: A Series of Case Studies. American Journal of Reproductive Immunology. 92(1). e13898–e13898. 3 indexed citations
8.
Mékinian, A., R. Bourguiba, Benjamin Terrier, et al.. (2023). AB1456 BIOLOGICS AND JAK INHIBITORS EFFICACY IN VEXAS SYNDROME FROM FRENCH MULTICENTER CASE SERIES OF 256 PATIENTS. 1955.1–1956. 1 indexed citations
9.
Carrat, Fabrice, et al.. (2022). Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients. Scientific Reports. 12(1). 12403–12403. 13 indexed citations
10.
Chopin, D, et al.. (2021). Arthrite septique primitive à Neisseria meningitidis. 2(4). 413–414.
11.
Ricard, Laure, Déborah Eshagh, Florent Malard, et al.. (2021). TFH cells in systemic sclerosis. Journal of Translational Medicine. 19(1). 375–375. 9 indexed citations
12.
Zhao, Lin‐Pierre, Emmanuelle Clappier, Marie Sébert, et al.. (2021). Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease. Leukemia. 35(9). 2720–2724. 25 indexed citations
13.
Jachiet, Vincent, Pierre Fenaux, Yervand Hakobyan, et al.. (2021). Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes. SHILAP Revista de lepidopterología. 2(2). 329–346. 3 indexed citations
14.
Genthon, Alexis, Thibault Chiarabini, Nadia Valin, et al.. (2021). Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Leukemia & lymphoma. 62(6). 1502–1505. 9 indexed citations
15.
Saadoun, David, Amine Ghembaza, Sébastien Rivière, et al.. (2020). Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study. Journal of Autoimmunity. 116. 102577–102577. 15 indexed citations
16.
Grignano, Éric, A. Mékinian, Thorsten Braun, et al.. (2016). Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. Leukemia Research. 47. 136–141. 36 indexed citations
17.
Mékinian, A., Jonathan Cohen, Jaume Alijotas‐Reig, et al.. (2016). Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?. American Journal of Reproductive Immunology. 76(1). 8–28. 121 indexed citations
18.
Soussan, Michaël, Patrick Nicolas, Catherine Schramm, et al.. (2015). Management of Large-Vessel Vasculitis With FDG-PET. Medicine. 94(14). e622–e622. 198 indexed citations
19.
Mékinian, A., Ryad Tamouza, Stéphan Pavy, et al.. (2011). Functional study of TNF-α promoter polymorphisms : literature review and meta-analysis. European Cytokine Network. 22(2). 88–102. 65 indexed citations
20.
Mékinian, A., M. Lambert, V. Queyrel, et al.. (2008). Maladie de Still de l’adulte et angiosarcome hépatique, une association fortuite ou un syndrome paranéoplasique : à propos d’un cas. La Revue de Médecine Interne. 29(11). 936–939. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026